Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat versus placebo and salmeterol in adults with moderate persistent asthma
2009-018005-43Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium and salmeterol in asthma (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Peak FEV1 response, Trough FEV1 response and 1 more. Started May 2010; status: completed.
02
Drugs
tiotropiumsalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-018005-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018005-43.